Journey Medical
DERM
38 hedge funds and large institutions have $30M invested in Journey Medical in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 5 closing their positions.
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
102% more capital invested
Capital invested by funds: $14.8M → $30M (+$15.2M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
4.27% more ownership
Funds ownership: 25.44% → 29.71% (+4.3%)
3% more funds holding
Funds holding: 37 → 38 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.58M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$634K |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$341K |
| 4 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$311K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$232K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OWP
ORG Wealth Partners
Dallas,
Texas
|
-$81.6K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$80K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$61.9K |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$58.6K |
| 5 |
NL
NWAM LLC
Mercer Island,
Washington
|
-$41.5K |
DERM Hedge Fund Activity: Q1 2025 in Review
38 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q1 2025, worth a combined $30M — up 102% from $14.8M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new DERM positions and 5 closed out — a net gain of 1 holder — while 17 added to existing stakes and 7 trimmed.
The largest buyer was Wasatch Advisors, opening a new position worth an estimated $4.58M. The largest seller was ORG Wealth Partners, exiting entirely with an estimated $81.6K sold.
- 38 institutional investors held Journey Medical (DERM) as of Q1 2025, up from 37 in Q4 2024.
- Funds reported $30M of Journey Medical stock for Q1 2025, up 102% quarter-over-quarter.
- 6 funds opened new Journey Medical positions in Q1 2025 and 5 closed out, a net change of +1 holder.
- The largest Journey Medical buyer in Q1 2025 was Wasatch Advisors, an estimated $4.58M added.
- The largest Journey Medical seller in Q1 2025 was ORG Wealth Partners, an estimated $81.6K sold.
Based on aggregated 13F filings for Q1 2025.